Abstract:Aims Positive associations between periodontitis (PD) and atherosclerosis have been established, but the causality and mechanisms are not clear. We aimed to explore the causal roles of PD in atherosclerosis and dissect the underlying mechanisms. Methods and Results A mouse model of PD was established by ligation of molars in combination with application of subgingival plaques collected from PD patients, and then combined with atherosclerosis model induced by treating atheroprone mice with a high-cholesterol diet (HCD). PD significantly aggravated atherosclerosis in HCD-fed atheroprone mice, including increased en face plaque areas in whole aortas and lesion size at aortic roots. PD also increased circulating levels of triglycerides and cholesterol, hepatic levels of cholesterol, and hepatic expression of rate-limiting enzymes for lipogenesis. Using 16S rRNA gene sequencing, F. nucleatum was identified as the most enriched PD-associated pathobiont that present in both oral cavity and livers. Co-culture experiments demonstrated that F. nucleatum directly stimulated lipid biosynthesis in primary mouse hepatocytes. Moreover, oral inoculation of F. nucleatum markedly elevated plasma levels of triglycerides and cholesterol and promoted atherogenesis in HCD-fed ApoE-/- mice. Results of RNA-seq and Seahorse assay indicated that F. nucleatum activated glycolysis, inhibition of which by 2-deoxyglucose in turn suppressed F. nucleatum-induced lipogenesis in hepatocytes. Finally, interrogation of the molecular mechanisms revealed that F. nucleatum induced glycolysis and lipogenesis by activating PI3K/Akt/mTOR signaling pathway in hepatocytes. Conclusions PD exacerbates atherosclerosis and impairs lipid metabolism in mice, which may be mediated by F. nucleatum-promoted glycolysis and lipogenesis through PI3K/Akt/mTOR signaling in hepatocytes. Treatment of PD and specific targeting of F. nucleatum are promising strategies to improve therapeutic effectiveness of hyperlipidemia and atherosclerosis. Translational Perspective This study has reinforced the causal relationship between PD and atherosclerosis, and identified F. nucleatum-mediated hepatic glycolysis and lipogenesis as a new mechanism underlying the causal relationship. These findings support that intervention of PD or F. nucleatum may improve lipid homeostasis and contribute to alleviation of atherosclerosis and improvement of cardiovascular health.

Acceleration of HDL-Mediated Cholesterol Efflux Alleviates Periodontitis

Acceleration of HDL-mediated cellular cholesterol efflux alleviates periodontitis

Disruption of cholesterol homeostasis triggers periodontal inflammation and alveolar bone loss

Periodontitis exacerbates atherosclerosis through Fusobacterium nucleatum-promoted hepatic glycolysis and lipogenesis

Effect of Hyperlipidemia on Periodontitis Progress in Apolipoprotein E Knockout Mice

Enhancement of Intracellular Cholesterol Efflux in Chondrocytes Leading to Alleviation of Osteoarthritis Progression

The association between high-density lipoproteins and periodontitis

Potential of alveolar bone damage in periodontitis patients with dyslipidemia

Hyperlipidemia Causes Changes in Inflammatory Responses to Periodontal Pathogen Challenge: Implications in Acute and Chronic Infections

Enhancing intracellular cholesterol efflux in chondrocytes alleviates osteoarthritis progression

Hyperlipidemia Impaired Innate Immune Response to Periodontal Pathogen Porphyromonas Gingivalis in Apolipoprotein E Knockout Mice.

[Hyperlipidemia Inhibited Inflammatory Response to Porphyromonas Gingivalis in Apolipoprotein E Knockout Mice].

Periodontal therapy improved lipoprotein-associated phospholipase A2 and lipid levels in serum of chronic periodontitis subjects with hyperlipidemia

Lipoprotein-associated Phospholipase A2 and Serum Lipid Levels in Subjects with Chronic Periodontitis and Hyperlipidaemia

The protective role of CD73 in periodontitis: preventing hyper-inflammatory fibroblasts and driving osteoclast energy metabolism

Facile Engineering of Resveratrol Nanoparticles Loaded with 20(S)-Protopanaxadiol for the Treatment of Periodontitis by Regulating the Macrophage Phenotype.

Deferoxamine Treatment Effectively Prevents Periodontitis Progression by Reducing Inflammation and Osteoclastogenesis in Experimental Periodontitis Rats

[Effect of Periodontal Initial Therapy on the Serum Level of Lipid in the Patients with Both Periodontitis and Hyperlipidemia].

Role Of Pcsk9 In The Development Of Mouse Periodontitis Before And After Treatment: A Double-Edged Sword

Synthetic high-density lipoprotein (sHDL): a bioinspired nanotherapeutics for managing periapical bone inflammation

Periodontitis and Atherogenesis: Causal Association or Simple Coincidence?